Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)

NCT: NCT06153667 · RECRUITING

NCT IDNCT06153667
StatusRECRUITING
Start Date2024-08-22
Completion2026-12

Brief Summary

This is a prospective, multicenter, observational, post-market clinical follow-up study in subjects treated with Bearing nsPVA Embolization Particles for uterine fibroid embolization. Data collection will include safety and performance outcome relating to the use of Bearing nsPVA, through 6 months.

Frequently Asked Questions

What is Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)?

Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE) is a clinical trial registered under NCT06153667. Current status: RECRUITING.

What is the status of NCT06153667?

The current status of NCT06153667 (Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)) is: RECRUITING.

When did Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE) start?

Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE) started on 2024-08-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑